Published in Br J Ophthalmol on February 01, 2001
The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol (2006) 1.62
Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med (2010) 1.39
Targeted deletion of AP-2alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma. Invest Ophthalmol Vis Sci (2005) 1.02
Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model. Invest Ophthalmol Vis Sci (2008) 1.01
Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. Jpn J Ophthalmol (2007) 0.97
Corneal Regeneration After Photorefractive Keratectomy: A Review. J Optom (2014) 0.95
Topical rosiglitazone is an effective anti-scarring agent in the cornea. PLoS One (2013) 0.87
Noninvasive intratissue refractive index shaping (IRIS) of the cornea with blue femtosecond laser light. Invest Ophthalmol Vis Sci (2011) 0.87
Cryopreservation of extracted corneal lenticules after small incision lenticule extraction for potential use in human subjects. Cornea (2014) 0.87
Corneal haze and visual outcome after collagen crosslinking for keratoconus: A comparison between total epithelium off and partial epithelial removal methods. Adv Biomed Res (2014) 0.84
Effect of base curve radius of therapeutic lenses on epithelial healing after laser-assisted subepithelial keratectomy. Korean J Ophthalmol (2007) 0.83
Topographical control of ocular cell types for tissue engineering. J Biomed Mater Res B Appl Biomater (2013) 0.82
Nuclear and cellular alignment of primary corneal epithelial cells on topography. J Biomed Mater Res A (2012) 0.82
Immunohistological evaluation of the healing response at the flap interface in patients with LASIK ectasia requiring penetrating keratoplasty. J Refract Surg (2009) 0.81
Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells. PLoS One (2014) 0.79
Assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas. Exp Eye Res (2014) 0.79
Clinical Outcomes of Small Incision Lenticule Extraction with Accelerated Cross-Linking (ReLEx SMILE Xtra) in Patients with Thin Corneas and Borderline Topography. J Ophthalmol (2015) 0.79
Comparable change in stromal refractive index of cat and human corneas following blue-IRIS. J Biomed Opt (2017) 0.75
Tissue and cellular biomechanics during corneal wound injury and repair. Acta Biomater (2017) 0.75
Contrasting cellular damage after Blue-IRIS and Femto-LASIK in cat cornea. Exp Eye Res (2017) 0.75
Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest (1990) 4.67
Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol (1990) 3.27
Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A (1996) 2.63
Excimer laser surgery of the cornea. Am J Ophthalmol (1983) 2.22
Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea (1996) 2.19
Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol (1995) 2.04
Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch (1994) 1.79
Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci (1995) 1.64
Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci (1998) 1.39
Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg (1995) 1.39
Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res (1998) 1.37
Corneal stromal wound healing in rabbits after 193-nm excimer laser surface ablation. Arch Ophthalmol (1989) 1.21
An in vivo investigation of the structures responsible for corneal haze after photorefractive keratectomy and their effect on visual function. Ophthalmology (1996) 1.14
One-year refractive results of central photorefractive keratectomy for myopia in the nonhuman primate cornea. Arch Ophthalmol (1990) 1.14
Importance of pathological intraocular light scatter for visual disability. Doc Ophthalmol (1986) 1.11
Laser vision correction for low hyperopia. An 18-month assessment of safety and efficacy. Ophthalmology (1998) 1.07
Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res (1997) 1.07
Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci (1998) 1.06
Human excimer laser lamellar keratectomy. A clinical study. Ophthalmology (1989) 1.03
Growth factors and ocular wound healing. Eye (Lond) (1994) 1.00
A refractive and histopathologic study of excimer laser keratectomy in primates. Am J Ophthalmol (1990) 0.99
Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol (1995) 0.98
Comparison of wound healing after photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Cataract Refract Surg (1999) 0.98
Histological, immunohistochemical, and ultrastructural findings in human corneas after photorefractive keratectomy. J Refract Surg (1995) 0.95
Corneal healing following laser refractive keratectomy. Arch Ophthalmol (1989) 0.94
Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci (1992) 0.94
Effects of transforming growth factor beta on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy. Graefes Arch Clin Exp Ophthalmol (1998) 0.87
In vivo confocal microscopy of corneal wound healing after excimer laser photorefractive keratectomy. CLAO J (1995) 0.84
SPARC from corneal epithelial cells modulates collagen contraction by keratocytes. Invest Ophthalmol Vis Sci (1998) 0.84
Corneal epithelial recovery following photorefractive keratectomy. Br J Ophthalmol (1996) 0.80
Excimer laser photorefractive keratectomy for high myopia and myopic astigmatism. Ophthalmic Surg Lasers (1999) 0.79
Photorefractive keratectomy for -1.25 to -25.00 diopters of myopia. J Refract Surg (1999) 0.79
Corneal epithelial permeability after excimer laser photorefractive keratectomy. J Cataract Refract Surg (1996) 0.79
Allergic conjunctivitis as a risk factor for regression and haze after photorefractive keratectomy. Am J Ophthalmol (1998) 0.79
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med (1999) 2.52
Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology (1997) 2.32
Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol (1995) 2.21
Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet (2001) 2.10
Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol (1998) 1.84
Dry eyes and video display terminals. N Engl J Med (1993) 1.82
Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol (1995) 1.73
Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann Rheum Dis (2001) 1.68
Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea (2001) 1.65
Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh) (1993) 1.63
Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol (1997) 1.57
Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant (2003) 1.55
Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. J Rheumatol (1996) 1.55
Posterior corneal protrusion after PRK. Cornea (1997) 1.52
Practical double vital staining for ocular surface evaluation. Cornea (1993) 1.50
Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology (1998) 1.49
Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology (1995) 1.48
Teaching continuous curvilinear capsulorhexis using a postmortem pig eye with simulated cataract(2)(2). J Cataract Refract Surg (2001) 1.47
Dry eye after laser in situ keratomileusis. Am J Ophthalmol (2001) 1.46
Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol (2001) 1.45
Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia (2010) 1.42
Abnormal blinking of newscasters. Lancet (1999) 1.41
Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol (1997) 1.40
The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol (1991) 1.39
Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea (1999) 1.30
Tear function index. A new measure of dry eye. Arch Ophthalmol (1995) 1.30
Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surg Lasers (1998) 1.27
Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol (1999) 1.26
A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25
Decrease in corneal sensitivity and change in tear function in dry eye. Cornea (1996) 1.17
A new surgical technique for deep lamellar keratoplasty with single running suture adjustment. Am J Ophthalmol (1998) 1.17
Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea (2001) 1.13
Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers (1996) 1.10
The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis. Allergy (2007) 1.08
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J Immunol (1999) 1.08
A ring to support the capsular bag after continuous curvilinear capsulorhexis. J Cataract Refract Surg (1994) 1.08
Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal (1993) 1.07
Adenocarcinoma of the ciliary body pigment epithelium in a child. Arch Ophthalmol (1984) 1.06
Dry eye after refractive surgery. Curr Opin Ophthalmol (2001) 1.06
Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci (1998) 1.06
Thermal effect on corneal incisions with different phacoemulsification ultrasonic tips. J Cataract Refract Surg (1999) 1.06
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant (2007) 1.05
Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin Exp Immunol (1998) 1.04
Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol (2002) 1.04
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. Cornea (2001) 1.02
Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J Clin Invest (1996) 1.00
Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol (1999) 1.00
Excimer laser-induced hydroxyl radical formation and keratocyte death in vitro. Invest Ophthalmol Vis Sci (1999) 0.99
Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy (2008) 0.99
Decreased tear lipocalin concentration in patients with meibomian gland dysfunction. Br J Ophthalmol (2005) 0.99
Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study. Cornea (1996) 0.98
Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol (1995) 0.97
Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology (2000) 0.97
Clinical features of a newly recognized type of lattice corneal dystrophy. Am J Ophthalmol (1987) 0.97
Measurement of fornix depth and area: a novel method of determining the severity of fornix shortening. Eye (Lond) (2008) 0.96
Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol (2002) 0.95
Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells. Br J Ophthalmol (2006) 0.95
Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry. Br J Ophthalmol (1996) 0.95
Creating cataract in a pig eye. J Cataract Refract Surg (1999) 0.95
Corneal endothelial cell loss induced by air bags. Ophthalmology (1993) 0.95
Morphology and barrier function of the corneal epithelium after penetrating keratoplasty: association with original diseases, tear function, and suture removal. Cornea (1999) 0.95
Formation of dioxins (PCDDs/PCDFs) by dioxin-free fly ash as a catalyst and relation with several chlorine-sources. Chemosphere (2000) 0.94
Subthreshold UV radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin. Exp Eye Res (1996) 0.94
Effect of laser in situ keratomileusis correction on contrast visual acuity. J Cataract Refract Surg (2001) 0.94
Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant (2009) 0.93
Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea (1996) 0.92
Pterygium and dry eye. Ophthalmologica (2001) 0.92
Allergic conjunctivitis and dry eye. Br J Ophthalmol (1996) 0.92
Sensitivity and specificity of photopic negative response of focal electoretinogram to detect glaucomatous eyes. Br J Ophthalmol (2009) 0.91
Alterations of the tear film and ocular surface health in chronic smokers. Eye (Lond) (2008) 0.91
Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol (1995) 0.91
Poor illumination, VDTs, and desiccated eyes. Lancet (1996) 0.91
Cytologic evaluation of conjunctival epithelium using Cytobrush-S: value of slide preparation by ThinPrep technique. Cytopathology (1997) 0.91
Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol (1999) 0.91
Trabeculectomy with mitomycin C for post-keratoplasty glaucoma. Br J Ophthalmol (2000) 0.90
Iatrogenic cataract after laser-assisted in situ keratomileusis. Am J Ophthalmol (1999) 0.90
Quantitative evaluation of atopic blepharitis by scoring of eyelid conditions and measuring the water content of the skin and evaporation from the eyelid surface. Cornea (2001) 0.90
Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol (1995) 0.90
Long-term follow-up of patients with familial subepithelial amyloidosis of the cornea. Ophthalmology (1995) 0.90
Lacrimal punctal occlusion for the treatment of superior limbic keratoconjunctivitis. Am J Ophthalmol (1997) 0.89
Three year prospective, randomized evaluation of intraocular lens implantation through 3.2 and 5.5 mm incisions. J Cataract Refract Surg (1998) 0.89
pH changes of self-etching primers mixed with powdered dentine. J Dent (2008) 0.89
Detection of hepatitis C virus RNA in tears and aqueous humor. Am J Ophthalmol (1994) 0.89
Intraoperative versus postoperative suture adjustment after penetrating keratoplasty. Cornea (1998) 0.88
Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin Exp Allergy (2006) 0.88
Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone. Br J Ophthalmol (2000) 0.88
Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci (2000) 0.87
Prospective randomized comparison of DisCoVisc and Healon5 in phacoemulsification and intraocular lens implantation. Eye (Lond) (2010) 0.87
Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands. J Clin Pathol (1996) 0.87
Changes of corneal redox state in diabetic animal models. Cornea (1995) 0.87
Trabecular surface remodeling simulation for cancellous bone using microstructural voxel finite element models. J Biomech Eng (2001) 0.87
Real-time telemedicine in the clinical assessment of the ocular surface. Am J Ophthalmol (1998) 0.87
Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea (1995) 0.87
Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy (1997) 0.87
Temporary corneal stem cell dysfunction after radiation therapy. Br J Ophthalmol (1996) 0.87